
A Phase 1/2 Dose-Ranging Safety and Immunogenicity Study of mRNA-Based Candidate Pandemic Influenza Vaccines in Healthy Adults
✅ Just Accepted
🔗 bit.ly/434CDLB

English
Clinical Infectious Diseases
3.6K posts

@CIDJournal
The world's leading journal on infectious diseases. Clinical ID, public health, microbiology, and everything in-between. Official publication of @IDSAinfo






































